Melasma Drug Market to Witness Strong Growth with Increasing Female Patient Base
The global melasma drug treatment market is witnessing steady growth as awareness around skin health and cosmetic dermatology continues to rise. Valued at US$ 2.6 Bn in 2022, the market is projected to surpass US$ 5.2 Bn by 2031, expanding at a CAGR of 8.3% during the forecast period. Increasing prevalence of melasma, particularly among women, along with advancements in treatment technologies,...
0 Comments 0 Shares 9 Views 0 Reviews
MakeMyFriends https://makemyfriends.com
SiteLock